Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

13.07
-0.5400-3.97%
Post-market: 13.100.0300+0.23%19:58 EDT
Volume:5.65M
Turnover:74.04M
Market Cap:1.29B
PE:-2.24
High:13.59
Open:13.56
Low:12.88
Close:13.61
52wk High:39.89
52wk Low:12.88
Shares:98.32M
Float Shares:80.72M
Volume Ratio:1.21
T/O Rate:7.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-4.42
PE(LYR):-2.24

Loading ...

May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2026

Major Issues Report

Form 8-K - Current report
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 02, 2026

Major Issues Report

Form 8-K - Current report
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Major Issues Report

Form 8-K - Current report
Feb 18, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2026

Major Issues Report

Form 8-K - Current report
Feb 03, 2026

Major Issues Report

Form 8-K - Current report
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report